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Health care spending in the United States continues to escalate; it is now nearly 18 percent 
of the gross domestic product. A number of major efforts across country are attempting 
to understand, measure, and ultimately slow the rate of spending growth. Many efforts 
also seek to publicly report information about price, cost, and spending. Yet each of these 
initiatives is hampered by the problem of defining and quantifying cost and spending, and 
many are trying to understand and measure economic variables in novel ways. As these 
measurement initiatives develop, those attempting this work almost immediately face a 
series of fundamental questions. Definitions matter in this effort. The varying perspectives 
of stakeholders do as well. In June 2011, the Robert Wood Johnson Foundation (RWJF) 
convened a meeting of leading experts in Washington, D.C., to discuss the difficulties 
of cost and spending measurement and reporting. Leading experts from health plans, 
employers, government and philanthropic organizations, and others sought to develop 
practical guidance for the field in measuring price, cost, and spending. Strategies discussed 
in that meeting inform this paper.
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P
icture a business traveler who needs to fly from 
Atlanta to New York City. She has a plethora of 
factors to consider when buying a ticket for a 
flight. These include which New York-area airport 
she would like to use; departure and arrival times; any 
loyalty or rewards programs she might have with a 
particular airline; and the price of the ticket. She’s likely 
to think about each of these factors based on her own 
needs when buying her ticket.
Price matters to her. It’s not the only variable that 
matters, but it is one of many relevant issues she will 
take into account. Yet the factors that help create that 
price likely do not matter to her at all. She doesn’t 
care about the cost of jet fuel, higher landing fees, or 
the salaries of the pilot and crew. The airline’s profit 
margin or quarterly return to shareholders is of little 
interest to her. She just wants to know what her ticket 
will cost her. She does recognize that the price of the 
ticket does not include everything she will spend—that 
she’ll face extra charges to check a bag, for instance, 
and that her decision on which airport she uses will 
influence the time and price of her transport from the 
airport to her hotel. But for the most part, the price of 
the ticket is a known quantity that she can consider 
when making her decision. She can find out the price 
of a ticket easily—through an Internet-based travel 
agent or by contacting the airline directly—and the 
price she is quoted is the price she will pay.
Now picture the pilot. His contract is up for renewal 
and his labor union is negotiating a pay increase. The 
airline says it can’t be done and cites higher and rising 
jet fuel costs as two reasons why. The pilot’s union, 
unlike the business traveler, cares very much about 
these costs, because the union needs to take them 
into account in understanding what the airline can or 
cannot afford to pay its members.
Consumers, businesses, oversight bodies, 
and other stakeholders encounter these same 
issues in every industry. And in every industry, 
the costs, prices, and total spending are often 
easily understandable.
But not in health care. Why?
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T
he measurement of price, cost, and spending is a key 
ingredient in building an accountable health care system. 
Multiple stakeholders would benefit from a coherent 
measurement system. Yet measurement of these economic 
variables remains extraordinarily challenging. 
There is, as top health economists have observed, “an almost 
complete lack of understanding of how much it costs to deliver 
patient care.”1 Little is known about how prices are derived. The 
answer to the basic question of what health care costs often is 
unknown.2 Payers see a bill, but generally are given very little 
detail about how prices in that bill are determined.
The resultant health care cost and pricing black box is 
increasingly unacceptable to many stakeholders. Health care 
professionals and payers face legitimate demands from purchasers 
of care, policy-makers, and the general public to conduct their 
business more transparently. 
Of course, we do have some information. In fact, 
considerable data on prices and spending exist today. For 
example, at a national level, health expenditure accounts are 
well established—thus allowing policy-makers to conclude with 
confidence that the United States spends significantly more per 
capita on health care than does any other nation.3 At a more 
granular level, health plans all know the prices they pay for health 
care services.
But questions remain about the accuracy and utility of the 
data that are currently available to the public and purchasers 
of care. Overall, data on price, cost, and spending are sparse, 
diffuse, and poorly organized and presented. Often, data are 
aggregated in ways that do not facilitate choice, negotiation, or 
accountability. Consider:
•	 Consumers are increasingly asked to make health care 
decisions based on price. This point is especially true for 
patients in high-deductible health plans (but not exclusive 
to those patients). Therefore, these consumers are able to 
track out-of-pocket expenses but typically do not enter 
the health care marketplace armed with price information. 
Even in those rare instances in which they do, they lack 
comparative information with which to make decisions and 
therefore have trouble acting on price. Further, insurance 
can distort their incentives. Because the health plan picks 
up most of the bill, consumers today often have no incentive 
to choose based on price. Instead, they act on the out-of-
pocket price (i.e., co-payment) that they face, which may 
not offer the incentives to consume care efficiently. In some 
cases, the out-of-pocket price may actually discourage use of 
effective care or encourage use of low-value care.
•	 Like suppliers in any industry, health care providers have to 
allocate overhead costs to specific services (e.g., a procedure, 
an office visit). But in the health care industry, this 
allocation has too often been done in a way that obscures 
the cost of producing the service. 
•	 Health insurers seldom know the costs of producing care. 
From their perspective, the cost is the price paid for each 
unit of service multiplied by the frequency of services. The 
mix of services, and the variation in price per unit paid to 
different providers, makes it difficult to glean the reasonable 
cost of producing care for an individual plan member. 
•	 While some insurers do profile providers based on an 
episode of care, the information is often based on claims 
and discounts, and thus may not be the best or most useful 
information. Other insurers don’t have access to such 
information at all for proprietary reasons, making it more 
difficult for purchasers to get usable aggregate information 
in a local market.
•	 The historical ability for health plans to simply pass on the 
increase in total cost of care to employers has shielded plans 
from understanding the true costs of care and applying 
normal market mechanisms to control rising costs. 
•	 Insurance has a “distorting effect” on measuring cost as well 
because many health care prices are determined not by what 
it costs to produce them, but rather by what insurers will 
pay. Additionally, because health care services are billed to 
insurers as discrete units rather than as bundles of care, they 
must do additional analysis or purchase specific software to 
assess cost of care for an episode. 
The Measurement Conundrum
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Definition of Terms
Definitions matter. It is important to be 
precise when discussing price, cost, 
and other issues related to health care 
spending, because without precision 
these issues are easily confused. 
Throughout this paper, the following 
terms are used:4 
Allowed amount: The most amount 
of money that a health plan will pay for 
a covered good or service. The allowed 
amount is negotiated between the 
plan and the provider, reflecting any 
discount the plan is able to achieve 
for its members. The allowed amount 
reflects the “true price” of health care, but 
allowed amounts usually are considered 
proprietary information and rarely are 
released to the public.5 
Charge: The maximum amount of money 
a provider would seek to be paid. This 
amount often is charged to patients who 
do not have health insurance; health plans 
typically negotiate the charge down to 
the allowable amount on behalf of their 
members.6 Charges in health care tend to 
be arbitrary and not reflective of true cost.
Claim: A request by a provider to an 
individual’s insurance company for the 
insurance company to pay for services 
obtained from a health care professional.7 
Cost: The dollar value of resources used 
to provide care—i.e., the costs of various 
inputs used in the production of a health 
care good or service.
Discount: The difference between the 
charge (the maximum amount of money 
a provider would seek to be paid) and the 
price (the actual amount of money the 
provider is paid). Discounts are usually 
negotiated by insurance carriers based 
on their power to bring a large amount of 
business to a provider.
Episode (or, Episode of Care): 
Commonly, a defined period of illness 
and/or treatment that has a certain start 
and end date. The National Quality Forum 
has defined an episode of care as “a 
series of temporally contiguous health 
care services related to the treatment 
of a given spell of illness or provided in 
response to a specific request by the 
patient or other relevant entity.”8 
Input: The factor used to produce a 
health care good or service, and the 
spending associated with that factor (e.g., 
nursing wages, prescription drug prices).
Price: The amount paid for a service or 
product, typically determined via market 
mechanisms that take into account the 
supply of and demand for the service or 
product.
Resource Use: A measure or set of 
measures intended to broadly capture 
indicators of the cost and efficiency 
of health care provisions. Health care 
resource use measures reflect the 
amount or cost of resources used to 
create a specific product of the health 
care system. The specific product could 
be a visit or procedure, all services 
related to a health condition, all services 
during a period of time, or a health 
outcome.9 “Relative” Resource Use 
(RRU) measures have been developed 
by the National Committee for Quality 
Assurance to indicate how intensively 
plans use physician visits, hospital stays, 
and other resources to care for members 
identified as having one of five chronic 
diseases: cardiovascular disease, chronic 
obstructive pulmonary disease, diabetes, 
hypertension, and asthma.10
Spending: The total amount of money 
spent on health care, including total 
resource use and unit prices.
Value: The health outcome per dollar 
of cost expended.11 Value incorporates 
product and service quality into the 
assessment of output, and also reflects 
the societal or personal value of the good 
or service consumed.
•	 The “unit” of cost and price is usually the service, not 
an entire episode or a bundle of care, which encourages 
a fragmented view of the health care system and makes 
it difficult for consumers, employers, and health plans 
to understand the total price paid for an episode and to 
compare that price paid for one provider with another. 
Yet while measurement of these economic variables 
is complex, there is great demand for such information. 
Measurement would be an important step toward giving multiple 
stakeholders the tools to make decisions, hold each other 
accountable, increase transparency, and behave as rational actors 
in an economic marketplace. 
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Health care is different, and that’s not OK
In virtually every industry, the participating actors (e.g., 
producers of goods, customers) have some information about 
price, cost, and spending information to help them make 
decisions. In most sectors of the economy, consumers can 
usually see the price of the services or goods they are purchasing. 
Producers and suppliers understand the unit costs relevant to 
them for the pieces they add or the items in the supply chain they 
are purchasing to add to the final product. 
In general, consumers do not need to understand the 
individual unit costs for all parts of a product or service. Instead, 
consumers are only interested in the piece that is relevant to 
them. For instance, if a consumer is buying a refrigerator, he does 
not care about the cost of the various parts of the refrigerator, or 
the transport costs of those parts to a manufacturing facility or 
retailer. That consumer likely does care, though, about his family’s 
total spending for kitchen appliances, so he can make sure the 
new refrigerator fits into the total household budget. 
Similarly, airline passengers don’t care how much jet fuel 
costs; how much each part of the plane costs; or the salaries of 
the pilots, flight attendants, and ground crew. Passengers care 
about a host of factors including safety, convenience, timeliness, 
efficiency, comfort, and amenities—and, ultimately, price. 
Usually, they care about their total spending for air travel over 
the course of a year, for family budgeting purposes. For their 
part, airlines absolutely care about fuel costs and labor costs, 
and understand those production costs to optimize value for 
the customer.
Many health care providers and others object to the drawing 
of a comparison between health care and other industries. They 
argue that health care is not a commodity and should not be 
treated as such.12 They have a point. Unlike a refrigerator or an 
airline ticket, health care often can be a life-or-death endeavor. If 
one does not need it (i.e., if one is healthy), one should buy very 
little; and if one needs it (i.e., if one is sick), cost becomes just 
one factor (often not the primary factor) in the quest to obtain 
the best treatment possible. Further, health care can be purchased 
“a la carte” as a one-time transaction (e.g., a knee replacement) 
or as a complete package (e.g., a year of diabetes care, including 
HbA1c tests and eye and foot exams), and patients may need or 
desire some of each type of care.
Yet American health care does not operate in a vacuum free of 
economic pressures. Doctors, nurses, and other health professionals 
need to get paid for their services. Drugs and medical equipment 
cost money. Hospitals and clinics have bills to pay. Like other 
industries, health care is subject to the laws of economics.
There are striking differences between health care and other 
industries, though. 
One difference is the importance of charity care. If a 
person needs health care and cannot afford to pay, he or she 
often still gets some care. This care often is poorly organized and 
coordination of that kind of care is extremely challenging, but it 
is care nonetheless—and has to be paid for, somehow. 
A second major difference is the public–private nature of 
the American health care system. Approximately half of health 
care in the United States is paid for by a governmental body (e.g., 
Medicare, Medicaid, the Department of Veterans Affairs, the 
Department of Defense, Indian Health Service). Government-
funded payers, particularly Medicare, can have an enormous 
influence on health care costs because they comprise so much of 
the market. Moreover, public financing of care and general policy 
interest in health care has led to a desire among many actors to 
find ways to hold the system accountable for spending. 
A third difference is that the payment of many health care 
services is done by a third-party insurer, not the consumer, thus 
shielding the consumer from the price of those services. It is true 
that this dynamic has shifted in the past decade. Consumers 
now must bear a higher percentage of their own care, and high-
deductible health plans have led some consumers to shoulder 
a constant and rising percentage of the cost of each service 
consumed. Yet high-deductible plans remain a minority, and 
even in instances where people use those plans, many prices are 
obscured from those consumers. Further, even though consumers 
using those high-deductible plans bear a greater burden of cost 
than they might under a traditional plan, they usually still only 
pay a small minority of these costs out-of-pocket. 
These differences, however, are not sufficient to justify the 
absence of pricing information or the lack of understanding of 
costs of production by health professionals. Health care might be 
complex, and the clinical pathways to treat a patient sometimes 
ambiguous, but that does not justify the inability to track the 
costs associated with the delivery of a unit of service.
There is, then, a dearth of information about price, cost, 
and spending. In some instances, data exist but are held as 
proprietary; in others, cost is a fundamentally unknown 
variable, thanks to decades of cost shifting and perverse 
financial incentives. Some costs and spending can be measured, 
and some data are available—but systems for reporting these do 
not measure costs or spending in units that are meaningful to 
any stakeholder.
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The importance of perspective
Different health care price, cost, and spending information 
matters to different actors. Thus, it is important to have different 
measures to satisfy different needs. 
For instance, consumers care about out-of-pocket price. 
Today, that typically refers to the price of a specific service, as 
if this service were delivered in a vacuum. However, consumers 
are seldom aware of out-of-pocket prices for an entire episode of 
treatment. They are usually made aware of that total only after 
the episode has concluded, and they add up the individual out-
of-pocket expenses. Even assuming identical quality (which is 
hardly a given), it makes little sense to choose the least expensive 
knee surgeon if he only operates at the most expensive hospital, 
for example. Consumers and patients should understand ahead 
of time their potential out-of-pocket expenses, and be spared 
information that they do not need.
Conversely, consumers arguably care about their household 
expense on health care (that is, the portion of insurance 
premium paid, Health Savings Account or Flexible Spending 
Account contributions, and out-of-pocket expenses). However, 
community-level measurement and comparisons that include 
the entire population—such as aggregate spending—are 
hardly interesting at all to those very consumers, because that 
information is not actionable information for them. Further, 
comparisons of cost and spending across communities are also 
not of great interest to consumers. (If spending is higher in 
Memphis than in Nashville, that’s interesting but not useful to 
consumers, because most of the time consumers can’t simply go 
to another community for care.) 
But this community-level information would be of great 
interest to policy-makers—and, to a lesser extent, purchasers—
because they can design interventions or negotiate based on these 
data. Policy-makers are interested in fostering accountability—
in identifying what works within the system and what does 
not, learning lessons from success, and interceding in failing 
organizations in order to help turn them into successful enterprises. 
What can measurement achieve?
It is a maxim in business that one can improve only that 
which one can measure. This point oversimplifies the challenges of 
cost and spending measurement but speaks to an essential truth: 
information enables decisions and, ultimately, empowers change. 
Measurement and reporting are not foreign to health care. 
Measures of clinical quality are routinely collected, risk-adjusted 
when necessary, and publicly reported. Yet the concept faces a 
new set of challenges when applied to price, cost, and spending, 
because these issues get directly at our financial well-being. Even 
so, multiple audiences would benefit from cost and spending 
measurement. They include:
•	 Providers, who need better internal cost accounting 
mechanisms and would benefit from more transparent cost 
information as a means to gauge their own performance, 
establish bundled (or “episode”) pricing, and identify 
efficient referrals;
•	 Employers and other purchasers, who could use cost 
and spending information to help negotiate with health 
plans and providers. Better spending data can help them 
understand how their premium dollars are spent and gauge 
the relationship between spending and clinical quality; 
•	 Oversight bodies, which can use reliable price, cost, and 
spending information to identify fraudulent or otherwise 
mismanaged behavior, and also identify areas in which 
providers are excelling; and
•	 Consumers, who are increasingly being asked to make 
health care decisions based on price, especially depending 
on the design of some high-deductible health plans—and 
who arguably can know their respective out-of-pocket 
expenses but still lack comparative information with which 
to make decisions.
Yet significant questions remain about reporting that 
information. These include questions about whether the 
varying information can be presented in such a way that 
various audiences, including but not limited to consumers, can 
understand and use it; whether publicly available price, cost, and 
spending information can change behavior; and whether these 
data can fairly depict noteworthy exceptions in the circumstances 
of individual reporting entities (e.g., fair representations of 
differences in providers’ circumstances or patient populations).13 
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D
ifferent measures indicate different things. Different 
audiences have different perspectives, needs, and 
capacities for understanding and using information. 
Stakeholders respond to data revealed by measures 
depending on what exactly those data reveal and how they are 
presented. In general, these measures can be used to enable:
•	 choice (e.g., managerial, purchaser, or consumer decisions); 
•	 negotiation (e.g., to set provider reimbursement rates); and 
•	 accountability (e.g., global cost budgeting; public reporting 
to policy-makers, public or private purchasers, oversight 
organizations, or entities like accountable care organizations 
and Aligning Forces for Quality). 
Thus, given the range of uses for the information, 
multiple types of measures are needed. Some already exist; 
others can be developed based on existing data; and still 
others demand new measures as well as a new culture of 
collaboration, openness, and trust so that stakeholders know 
the data will be used for their intended purposes. Each 
measurement endeavor, though, has different goals and faces 
different challenges and conceptual difficulties.
Measurement tools for cost do exist. These tools include 
standardized metrics and measure trends reasonably well. They 
accomplish what they were designed to accomplish. They are 
actuarial cost models that allow reasonable estimates to predict 
the future, are population-based, and allow adjustments for 
demographics and patient risk. But these tools are limited in 
what they can do, in that they do not match at all with health 
professional or plan quality metrics, and they treat diseases and 
treatments as stand-alone events rather than within the context 
of a whole person. In short, we are still missing “person-centric” 
spending tools.14
Each measurement goal (choice, negotiation, accountability) 
should ideally help lead toward more efficient health care, helping 
fulfill one of the Institute of Medicine’s six domains of quality.15 
It is important to note that efficiency does not necessarily mean 
lower costs, nor does it necessarily mean lower overall health 
care spending. In fact, more efficient use of resources may very 
likely lead to higher episode costs and higher spending but also, 
importantly, to improved quality of life—an essential goal of 
the health care system. This result of the drive toward efficiency 
could obviously have wide economic, societal, and political 
implications—but we cannot understand the impact of efforts to 
improve efficiency if we do not measure them.
Who Needs What? Types of Measurement  
and Audiences That Need It
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Purchasers of Care
Health plans and employers need comparative data on price 
in order to negotiate on it. Because these data are not available in 
most instances, and because plans and employers are interested in 
accountability as well as negotiation, many plans and employers 
are interested in provider costs instead of or in addition to price. 
Yet many of these cost data are also unavailable to health plans 
and purchasers. In fact, some hospitals do a poor job of tracking 
their own unit costs and thus are unable to report them with any 
degree of accuracy. While some hospitals may have a handle on 
some of their costs, they usually lack systems to track them in 
ways that are clinically meaningful and facilitate managing for 
value. Many physicians and other health care professionals lack 
the systems to accurately identify the cost associated with an 
individual office visit, let alone an episode composed of multiple 
office visits to multiple health care professionals.
Understanding and setting unit costs in health care is so 
divorced from reality that attempting to rationalize cost in one 
area is like pushing on a balloon: the surface is depressed in one 
area, but the amount of air doesn’t change and the balloon just 
expands elsewhere. 
Thus, purchasers of care would benefit from the 
development of cost measures for purposes of negotiation. 
Measuring cost for the purpose of negotiation is a difficult task 
because, much as with price measures for choice, cost measures 
for negotiation can conceivably be created along discrete service 
lines but are difficult to create across the panoply of needs that a 
patient is likely to have.
Is Measurement 
Analogous with 
Reporting?
In health care quality, measurement of 
clinical or other data often goes hand 
in hand with public reporting of those 
data—but not always.
Many describe public reporting to be like 
shining a light on the often opaque world 
of clinical medicine. Advocates for public 
reporting assert that the public has a right 
to know as much information as possible, 
and that withholding that information has 
an infantilizing effect on the public. 
However, this point is a matter of some 
debate. Some health care providers 
counter that the public is not prepared 
to understand certain clinical quality 
measures and that their public reporting 
would discourage providers from being 
truthful in data collection. Yet the collection 
of these data is still considered useful for 
internal quality improvement purposes—
that is, providers can use them to track 
their own performance over time. 
Therefore, there is an ongoing tension 
between the desire to measure clinical 
data for public reporting and the desire 
to use them to improve quality while not 
publicly reporting them. There is a similar 
tension between measurement and 
reporting of cost and spending data.
Consumers need price information—
but by and large do not need cost 
information. In fact, cost information is 
likely extraneous information to them 
and the public release of that cost 
information specifically for consumers 
may paradoxically have unintended 
deleterious or frustrating consequences 
with respect to those consumers.16 But 
other stakeholders (e.g., purchasers) do 
need cost information at least as much 
as, if not more than, price information, 
in order to negotiate with providers and 
to encourage accountability. A public 
release of that cost information targeted 
for purchasers, for instance, may be 
extremely useful for and well received  
by that audience.
Thus, cost and spending information 
should be measured rigorously. But the 
question of whether cost and spending 
(as opposed to price) information should 
be routinely publicly reported and for 
whom is less settled. It is much more 
important that consumers have access 
to accurate, well-presented, easily 
understandable price information than 
cost information. Public reporting and 
availability of price information to support 
decision-making is crucial. Wide public 
availability, however, of cost information 
is of secondary and limited value to 
consumers. Other key actors, like 
purchasers, could use cost information. 
Therefore, efforts to disseminate cost 
information might be more effective if 
targeted for purchaser, as opposed to 
consumer audiences. Measurement of 
the various price, cost, and spending 
information can logically lead to routine 
wide public reporting, but not necessarily. 
Further, public reporting efforts should 
consider carefully both the intended use 
of and audience for the given price, cost, 
or spending information. 
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Additional development and use of episode-of-care cost 
or spending measures beyond the current episode groupers, 
for instance, would be helpful to aid negotiation. Ideally, 
these measures should be open source, meaning that they 
would be widely available and used. Further, once constructed, 
these measures should also be transparent to all stakeholders. 
Importantly, though, episode-of-care measures require, at a 
minimum, transparency of the key, real underlying costs and 
allowed amounts. Unfortunately, those who currently hold the 
critically important data regarding underlying costs and allowed 
amounts—providers and health plans—have so far in most 
instances resisted the release of that information. 
In addition to negotiation, employers and other purchasers 
of care also are interested in accountability measures. 
Accountability—the desire to hold providers responsible for 
the quality and efficiency of care they provide—is a prime driver 
behind health reform efforts. Many purchasers are participating 
in multiple initiatives that are seeking to hold the health care 
system as a whole accountable for care spending. In addition, 
other initiatives such as Aligning Forces for Quality are also 
explicitly and heavily encouraging purchaser participation, and 
would be aided by accountability measures. 
Why Charges Don’t  
Tell Us Anything*
Reports of charges—the amount of money 
a provider would charge absent any 
discounts—often are used as an interim 
step to publicly reporting cost information. 
However, charge reporting is flawed at 
best and at worst misleading, because it is 
unrelated to actual payments.
Charges are based on aggregate data 
for estimating costs. They also are 
sometimes based on the assumption 
that every billable health care event 
in a given department has the same 
profit margin. This assumption, though, 
is obviously not the case. However, 
because charges are comparatively easy 
to collect and publicly report (in part 
because Medicare data on charges are 
publicly available), charge data often are 
used as a proxy for cost reporting.
In reality, charges billed and reimbursements 
paid do not reflect cost. The cost of using 
a resource (e.g., a physician, piece of 
equipment, or area of space) is the same 
whether it is reimbursed poorly or highly. 
Cost depends on how much time and 
supplies are used to care for a patient, 
not on the reimbursement of that service. 
Thus, charges do not tell us anything 
helpful about cost. 
* Adapted from Kaplan RS, Porter ME. How to solve 
the cost crisis in health care. Harv Bus Rev. Sept 
2011; 46-64.
Policy-makers
Policy-makers such as legislators, regulatory agencies, and 
nongovernmental oversight bodies need tools to gauge spending 
because their role is to hold health care providers and purchasers 
accountable for their behavior.
One significant initiative to establish accountability in 
health care spending is the development of Accountable Care 
Organizations, a payment and delivery reform model enabled 
under the Affordable Care Act that seeks to tie provider 
reimbursements to quality metrics and reductions in the total 
cost of care for an assigned population of patients. 
The goal of cost and spending accountability measures 
is to analyze cost and spending patterns over time and across 
settings of care in order to identify high-performing plans and 
providers (and learn from their examples) and low-performing 
plans and providers (to design interventions for improvement). 
If premiums rise from one year to the next, it would be useful 
to know what services were accounting for that—and spending 
increases could be compared with quality gains. Accountability 
demands a different set of measures than those consumers and 
purchasers might use for choice or negotiation, for instance. 
These accountability measures ideally would assess the impact on 
cost and spending that happens when multiple clinicians group 
together or organizations create incentives to coordinate care and 
hold clinicians accountable for that spending. 
One type of accountability measure, community-level cost 
and spending measures, is of interest to many. These are different 
measurements, though, than those accountability measures that 
attempt to assess cost and spending by individual plans, providers, 
or entities. Community-level measures are useful to policy-makers 
so they can compare costs and efficiency across geographic 
regions—so that they can learn, for instance, that a knee surgery 
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costs a certain amount in Nashville, Tenn. and more or less in 
Memphis, Tenn. Leaders could then adjust policies according 
to that insight. These community-level measures are, however, 
of relatively little practical utility to potential users within those 
communities (e.g., consumers, purchasers). Community-level 
measurement does not provide information upon which those 
people can practically act to reduce costs or spending.
Consumers
If they are interested in the financial impact of health care 
at all, consumers are interested in prices, not in costs—or at least 
they should be. 
Yet to a certain extent, consumers arguably already know 
the relevant price to them. That is, they know what they pay 
out-of-pocket (e.g., co-pays). However, this price information is 
for discrete services (e.g., a CT scan, a prescription medication) 
rather than for a complete set of services or management of 
a condition. Further, insurance distorts price or at least the 
consumer reaction to price. That is because a consumer often pays 
the same co-pay for a good or service even if he or she chooses a 
more expensive option. Additionally, the amount of a co-pay can 
vary greatly depending on the type of health plan the consumer 
uses, with amounts being unrealistically small for patients in 
traditional preferred provider plans, much higher in “consumer-
directed” plans, and certain services that have value do not 
require a co-pay at all (e.g., a “free” preventive care visit in a 
“value-based” insurance plan). The result is that price often takes 
on an air of fiction to consumers; the price isn’t “real.” Therefore, 
there is no need to react to it.
There are major barriers to good price measurement 
and reporting for consumers. There are few usable apples-to-
apples comparisons of care price in existence. For instance, a 
patient needing a knee replacement would have to do a great 
deal of research to compare prices among health professionals, 
and would likely encounter so much resistance and unusable 
information that the results of the research are likely to be 
meaningless. In fact, a major initiative would be necessary to 
standardize consumer-centric pricing to enable broad consumer 
choice based on price. The development of episode-of-care 
measures (see Page 13) may be helpful to develop these prices, 
but even these measures are not yet immediately or widely 
available.
Unfortunately, though, the problem is even worse. Insurance 
distorts the meaning and importance of price information to 
insured consumers. Further, many consumers are not properly 
prepared to understand—let alone make decisions based on—
price information. In fact, consumers simply may not be ready 
yet to use these data at all. Although most current research has 
for the most part only examined consumer reactions to health 
care costs or resource use rather than price or out-of-pocket cost, 
that research does raise important concerns regarding consumer 
readiness or willingness to use this type of information. These 
Does Efficient Mean Cheap?
Many consumers grow understandably nervous when they 
are told of efforts to make health care more efficient. Some 
consumers picture rationing of services, denial of needed 
care, or other efforts to cut spending by devaluing—even 
cheapening—care. 
But this would be a misrepresentation. Efficiency can be 
defined as “acting or producing effectively with a minimum 
of waste, expense or unnecessary effort” or “exhibiting 
a high ratio of output to input.”17 Another term for this is 
eliminating waste.
Health care is considered a highly wasteful system.18 19 
Thus, the Institute of Medicine (IOM) has declared that 
efficiency is one of the cornerstones of a high-quality health 
care system, along with safety, timeliness, effectiveness, 
equity, and patient-centeredness.20 Efficiency should never 
be confused for cheapness, because it’s not about denying 
necessary care; it’s about making sure that people who 
need care get the care they need—only the care they 
need—and that they actually benefit from that care.
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studies show that consumers often equate higher cost with higher 
quality when only given cost data, even though the exact opposite 
(i.e., higher cost may mean poorer quality) is often the case.21 
However, this last observation does not negate the need for price 
transparency. Instead, it demonstrates that price transparency 
carries a necessary educational component. Again, whether 
consumers like it or not, many will be increasingly forced to make 
decisions based on price as well as quality. It is unreasonable and 
unfair to ask them to do so in a price information vacuum.
In fact, consumers should be encouraged to consider 
price when making purchasing decisions, but that consumer 
consideration should be just one of many factors. Other factors 
should include clinical quality, convenience (i.e., proximity, 
timeliness), and non-quantifiable personal values (e.g., a hospital’s 
religious affiliation). As with every spending decision, consumers 
make choices based on a variety of considerations, and a rich 
and varied marketplace can cater to a variety of consumers, 
each of whom has different preferences. Price, however, must 
be one factor to consider, and the health care system owes it to 
consumers to give them good information so they can consider 
that factor fairly.
However, market research has demonstrated that consumers 
today are highly suspicious of efforts to achieve efficiency and 
value, and in fact associate the very word “value” with low quality. 
Consumers are reluctant to associate cost in any way with care, 
and when forced to do so often consider higher cost to be a proxy 
for higher quality.22 Thus, any serious measurement and reporting 
effort built to enable choice must distinguish between cost and 
price and must engage consumers with a sophisticated public 
education campaign.
Do We Really Need 
Price Measurement?
In our economy most prices are 
transparent. If a driver wants to buy a 
gallon of gasoline, the price per gallon is 
advertised on a sign on the highway, so 
the driver knows exactly what he or she 
is paying. 
Health care prices are less transparent. 
But they are not invisible. For example, 
many consumers know that a physician 
office visit will cost a $50 co-pay and that 
filling a prescription for a medication costs 
$25 (or $15 for the generic equivalent). 
To an insured consumer, the price is the 
co-payment and, in some cases, the 
deductible expense—that is, what he or 
she spends out-of-pocket on care. These 
prices tend not to change no matter what 
provider the consumer uses, although 
there is an exception under “tiered” 
insurance arrangements. This point is 
the “distorting” effect of insurance—that 
a consumer’s price is either known 
or is fundamentally knowable, but is 
nevertheless irrelevant because prices 
usually do not vary. Thus, for those 
with health insurance, price information 
definitely exists that could inform 
consumers—even if that information is at 
times opaque and difficult to discern or 
appreciate at the time of the transaction. 
That out-of-pocket price information 
certainly could be measured and 
presented in ways that would enhance 
consumer decision-making. 
For uninsured consumers or consumers 
who are covered under high-deductible 
health plans (e.g., “consumer-directed” 
plans), the picture is fuzzier. A physician 
office visit likely has a usual price 
that the consumer can learn when 
making an appointment, but most 
other health care transactions do not 
have a fixed price associated with 
them. An uninsured patient who needs 
a colonoscopy, for instance, would 
have a hard time estimating his out-of-
pocket expense before the procedure. 
Prices matter greatly to these patients. 
Unfortunately, because there exists no 
“bundled payment” way to estimate 
prices, these consumers still would be 
shopping for care on a per-treatment 
basis, not on an episode-based or 
person-based mechanism.
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T
oday, price, cost, and spending measurements are in their 
relative infancy. Yet significant work is being done to 
advance these, and the state of the science is improving. 
Innovative initiatives include:
•	 Aligning Forces for Quality  
Aligning Forces for Quality is RWJF’s signature effort to lift 
the overall quality and improve the value of health care in 
targeted communities.23 The Foundation’s commitment to 
improve health care in 16 communities is the largest effort 
of its kind ever undertaken by a U.S. philanthropy. While 
much of Aligning Forces’ initial work has focused on clinical 
quality improvement, several of these communities are 
now working to improve cost and spending of care in those 
markets as well. As part of that effort, those communities 
are working to report cost, resource use, and efficiency 
measures. They are starting with reporting basic charge 
information, usually based on Medicare or, in some cases, 
“all-payer” claims databases. 
 
In addition, all 16 Aligning Forces communities have 
identified specific community quality and cost and 
spending goals. These include goals such as reducing 30-
day readmissions to hospitals for heart attack and heart 
failure; reducing preventable hospital admissions for heart 
failure; and reducing emergency department utilization. 
So far, achievement of these goals often is measured by 
resource use (e.g., reducing 30-day readmissions for heart 
failure patients by 10 percent), which is associated with an 
assumed rather than measured cost savings. That means 
that these goals are using a measure of cost by proxy 
rather than actual measures of cost. This groundbreaking 
community work demonstrates some of the practical 
difficulties and the complexity in measuring cost. Some 
communities are reporting this information to the public. 
For instance, in Seattle, the Puget Sound Health Alliance 
has released a report on resource utilization for high-volume 
hospitalizations. The report was created by analyzing data 
for highly utilized hospital services, and indicators such as 
length of stay, medical tests, and examinations.  The report 
examines resource use through two lenses—intensity and 
appropriateness—and paints a picture of the value of such 
care in the Puget Sound region.24 
 
Additionally, several Aligning Forces communities are 
hosting cost “convenings” in which community stakeholders 
(e.g., health plans, providers, purchasers, consumer 
advocates) gather to discuss whether and and how to 
measure and report information.  
•	 State of Massachusetts 
Massachusetts is known for its universal coverage, which 
it achieved via an individual mandate. But it is also the 
first state to rigorously analyze cost data from the state’s 
private and public health care payers, providers, and acute 
care hospitals. The data collection and public reporting 
is pursuant to a 2008 law25 enacted to promote cost 
containment, transparency and efficiency in the health care 
delivery system.  
 
Under the law, the state’s Division of Health Care Finance 
and Policy holds an annual public hearing based on the 
collected data. The hearings are intended to focus not only 
on costs and cost trends, but the factors that contribute 
to cost growth within the health care system and the 
relationship between provider costs and payer premium 
rates.26 The attorney general may require testimony under 
oath and has previously released her own report, coinciding 
with the division’s reports. The attorney general reports have 
drawn conclusions about trends in payment and health care 
costs. The most recent attorney general report, released in 
the summer of 2011, recommended giving consumers more 
options to make value-based purchasing decisions through 
tiered and limited network health plans. The report also 
recommended institution of temporary cost controls to 
reduce variation in payment for comparable services until 
tiered and limited network health plans are functional.27
Developments in Measurement 
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•	 Federal efforts 
Federal law including the Affordable Care Act mandates 
several activities that get at payment reform, with an eye 
toward cost measurement. Interestingly, most of these 
efforts focus on resource use. These federal measurement 
efforts do not parse the many issues regarding price, cost, or 
spending. These efforts also presumably, for the most part, 
manage cost measurement with an accountability purpose 
or to enhance payment strategies. They include:
•	 The Centers for Medicare & Medicaid Services (CMS) 
have been phasing in the development of physician 
resource use reports to provide individual physicians and 
physician groups with confidential feedback allowing 
them to compare their resource use with other physicians 
in their specialty or in their geographic region.28
•	 CMS is funding development of a publicly available 
episode-of-care approach for six clinical conditions. (See 
below for more information on episodes of care.) CMS 
will use the logic behind the episodes to analyze resource 
use among physicians, which will be a critical element 
for Medicare’s physician feedback reporting program 
and for its value-based payment modifier. CMS will 
ultimately likely use the tool to compare one provider 
against another and thus identify the most efficient 
physicians, but not initially base payment from this 
component.29
•	 CMS currently is developing a value-based payment 
modifier that will eventually be applied to Medicare 
payments under the physician fee schedule, and should 
result in higher payments for higher quality care. This 
modifier will apply to some physician payments in 
2015 and to all physician payments by 2017.30
Development of global payment measures 
It is not conceptually or even practically that difficult to 
understand the price a consumer pays for a given physician office 
visit, nor is it a stretch for a hospital to understand how much a 
new piece of equipment costs. However, health care is more than 
a single event at a fixed point in time or a single new machine. It 
is a series of events over time, taking place in multiple settings and 
with multiple providers. So, while the consumer can understand 
the price of a single physician office visit, if that consumer 
has diabetes, he or she has a much harder time understanding 
what the prices will be over the course of a year of managing 
the disease; and, if he or she has multiple chronic conditions 
(e.g., diabetes and congestive heart failure), price measurement 
becomes even more difficult. 
There are innovative initiatives and studies that are 
attempting to rationalize cost measurement as a component of 
overall health care payment reform. These emphasize episode-
based care, which the National Quality Forum defines as a 
“longitudinal perspective [that] offers a more comprehensive 
assessment of resource use, including overuse and unnecessary 
use of services, as well as of the technical quality of the specific 
services that are delivered.”31 Its chief feature is bundled payments 
that promote adherence to guidelines, as with Geisinger Health 
System’s ProvenCare package for coronary artery bypass graft and 
elective percutaneous angioplasty32 and the PROMETHEUS 
Payment system’s “evidence-informed case rate.”33 The National 
Quality Forum has developed a significant amount of work, 
including a measurement framework, around episodes of care.34
Bundled payment based on or in the context of an episode-
of-care approach is an important development in payment 
reform. Episode costs or spending, if made public, may also be 
a good basis for patient and payer choice and negotiation with 
providers. But they are incomplete in and of themselves, because 
they measure care as it is delivered. These measures do not get 
at the appropriateness of the episode, nor do they account for 
multiple concurrent episodes.
Development of spending measures: 
Understanding appropriateness
Sometimes, the most appropriate care is the care that never 
happens in the first place. It has been estimated that the United 
States spends between one-fifth and one-third of our health care 
dollars—up to $700 billion a year—on care that does nothing to 
improve our health.35 This care not only weighs down our system 
economically; it also likely harms patients.
This insight has created a strong demand from policy-makers 
for measures of appropriateness. Episode-of-care measures are 
insufficient to measure appropriateness, because they measure 
care for episodes that were delivered, not whether the episode 
should have been delivered at all (e.g., was the hip replacement 
surgery needed). The goal of spending and appropriateness 
measures is to encourage not just efficient spending, but spending 
on the right thing. (The PROMETHEUS initiative did seek to 
address appropriateness by differentiating recommended and 
“typical” costs from potentially avoidable costs.)
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Spending measures could be focused on the whole patient, 
not on that patient’s treatment or condition. This type of 
spending measures could help draw a clear connection between 
cost measurement and clinical quality measurement. They 
would measure for clinically meaningful groups. And by doing 
so, they could also tie cost measurement to population health 
management. Ideally, spending measures should target specific 
populations (e.g., a specific ethnic group living in a particular ZIP 
code) and be able to risk-adjust for comorbidities, as do some 
measures of clinical quality.
The Robert 
Wood Johnson 
Foundation and 
Cost and Spending 
Measurement
The Robert Wood Johnson Foundation 
(RWJF), the nation’s largest philanthropy 
devoted solely to the public’s health, 
has committed to improving cost and 
spending measurement as part of its 
focus on improving health care for 
everyone in America, including how 
health care is delivered, paid for, and how 
well it does for patients and their families.
In addition to supporting the Aligning 
Forces for Quality initiative, RWJF is 
promoting payment reform in a variety of 
communities across the nation and has 
supported nascent efforts to measure the 
cost of care, particularly across episodes 
of care. Those cost measurement efforts 
include RWJF support for PROMETHEUS 
Payment and, previously, for the High-
Value Health Care Project with the 
Brookings Institution.36 37 Under the High 
Value Health Care Project, RWJF worked 
with the American Board of Medical 
Specialties Research and Education 
Foundation to develop measures of the 
cost of episodes of care.38
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C
urrent cost measurement tools work, in that they do what 
they were designed to do. They are, by and large, actuarial 
cost models—but they do not get at the full spending 
picture. Episode-based cost measures are helpful to a 
point, but they are not person-based. That means, for example, 
these episode-based measures would need to be augmented to 
account for multiple episodes for a person, or for situations in 
which services included in an episode are delivered at the same 
time as services that are not part of an episode (e.g., a person 
with depression who is also being treated for a broken arm). 
Current cost and spending measurement tools also do a poor 
job of measuring results for innovations and interventions such 
as disease management. There is often no connection between 
these tools and quality measures. In short, they are site-, service-, 
episode-, and condition-centric but not “people-centric.” 
Thus, it is fair to call current measurement efforts nascent, 
despite unprecedented hard work and collaboration by multiple 
stakeholders. The totality of initiatives, while well intentioned, 
do little to inform any actor in the health care marketplace, in 
part because no “Rosetta Stone” template exists to translate cost 
data to information for choice, negotiation, and accountability. 
What will it take to accelerate cost and spending 
measurement? The Aligning Forces Evaluation Team39 has 
identified four stages of community cost measurement: initiation, 
conceptualization, production, and dissemination.40 This effort 
starts with building stakeholder consensus around mutual 
goals—which can be the hardest part because it involves the 
setting aside of traditional suspicions and parochial concerns. 
In fact, some communities may not achieve consensus at all, 
depending on the purchaser-provider-plan dynamic in a given 
market. 
One big challenge for this effort is to identify the goals 
of measurement. This question is one that each group trying 
to measure will have to consider independently. Certainly, 
it would be nice to devote the enormous amount of needed 
resources toward the development of a full range of new 
measurement all at once. That spectrum of new measurement 
could provide important information for choice, negotiation, 
and accountability. Unfortunately, time and resources are limited, 
and that full spectrum approach is probably unrealistic. Thus, 
many communities will need to choose their measurement 
goal: choice, negotiation, or accountability—or some realistic, 
practical mix of those goals. Another key question: what 
resources are in fact available? Available resources will shape 
whether the measurement activity is done piecemeal (i.e., with 
individual measures and indicators) or as part of a comprehensive 
measurement approach. Everything else—the audience, the types 
of measures collected, what is done with the measures—flows 
from those decisions. 
Conclusion: Toward a focus on value
Health care’s various stakeholders are on a quest to achieve 
value—which is defined as the relationship between outcome 
and cost or, more specifically, the health outcome per dollar 
expended. In a competitive marketplace, the only way to 
transform health care in ways that drive toward value is to realign 
competition such that all actors are focused on achieving it.41
Value means different things to different stakeholders 
because, for instance, one entity’s cost may likely be another’s 
price. Health care is a $2.7 trillion industry in the United States, 
comprising 17.7 percent of the gross domestic product.42 It would 
be impossible to consider reforming the wide ranging pieces of 
health care in order to control spending without considering the 
impact of these reforms on various, disparate participants in the 
system.
Yet there can be little doubt that health care in the United 
States is too expensive today—that we spend too much and 
don’t derive better health outcomes as a result of that spending. 
Our current health care model or approach obviously and 
demonstrably does not focus on value—and for that reason 
is arguably unsustainable. The ultimate goal of efforts to 
transform health care, then, is to give people the various kinds of 
information they need so they can make the sorts of choices and 
decisions that, in aggregate, will ideally move health care toward 
high-quality at a lower overall cost. That is the quest for value. 
Measurement alone, of course, won’t create value. But 
it will enable it. Measurement of price, cost, and spending in 
clear, understandable terms that enables consumers, purchasers, 
Getting There from Here
What is the status of cost and spending measurement today?
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oversight bodies, health care professionals, and health plans 
to understand the way money interacts with health care is of 
paramount importance. Done correctly, that measurement will 
facilitate decision-making, provide a fair point of information 
for negotiation, and foster accountability. While such 
measurement will not be easy and is not without some risk, it 
comes with great rewards. Put simply: without it, we cannot 
pursue any truly serious effort to put U.S. health care on a path 
toward high value.
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